𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and tolerance of Gd-DOTA (DOTAREM) in healthy volunteers and in patients with chronic renal failure

✍ Scribed by A. Chachuat; P. Molinier; B. Bonnemain; C. Chambon; J. L. Gayet

Book ID
112276454
Publisher
Springer
Year
1992
Tongue
English
Weight
561 KB
Volume
2
Category
Article
ISSN
0938-7994

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

GD-DOTA: Evaluation of its renal toleran
GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure
✍ Marie-France Bellin; Gilbert Deray; Ubald Assogba; Eric Auberton; Farez Ghany; E πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 428 KB

Gd-DOTA is an intravenous contrast medium used in MRI. The clinical and biological tolerance of Gd-DOTA was studied in patients with chronic renal failure (e.g., those having a glomerular filtration rate of less than 60 mL/min). Twenty patients were randomized into two groups. In the control group,

Pharmacokinetics of intravenous diltiaze
Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers
✍ Maha Tawashi; Julien Marc-aurΓ¨le; Daniel Bichet; Jean SpΓ©nard; Lyne LariviΓ¨re; D πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 330 KB πŸ‘ 2 views

The pharmacokinetics of diltiazem were studied in seven patients with chronic renal failure (CRF) not requiring dialysis and in three healthy volunteers after a rapid i.v. infusion of 20mg. Mean plasma concentrations at the end of infusion were 3.15 times higher in patients with CRF than in healthy